Manufacturing of primed mesenchymal stromal cells for therapy

JQ Yin, J Zhu, JA Ankrum - Nature biomedical engineering, 2019 - nature.com
Mesenchymal stromal cells (MSCs) for basic research and clinical applications are
manufactured and developed as unique cell products by many different manufacturers and …

Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells

S Ceccariglia, A Cargnoni, AR Silini, O Parolini - Autophagy, 2020 - Taylor & Francis
Macroautophagy/autophagy occurs at basal levels in all eukaryotic cells and plays an
important role in maintaining bio-energetic homeostasis through the control of molecule …

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase …

J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans… - Cytotherapy, 2016 - Elsevier
Mesenchymal stromal cells (MSCs) as a pharmaceutical for ailments characterized by
pathogenic autoimmune, alloimmune and inflammatory processes now cover the spectrum …

Immunomodulatory effects of mesenchymal stromal cells-derived exosome

W Chen, Y Huang, J Han, L Yu, Y Li, Z Lu, H Li… - Immunologic …, 2016 - Springer
The mechanisms underlying immunomodulatory ability of mesenchymal stromal cells
(MSCs) remain unknown. Recently, studies suggested that the immunomodulatory activity of …

Potency analysis of mesenchymal stromal cells using a combinatorial assay matrix approach

R Chinnadurai, D Rajan, M Qayed, D Arafat, M Garcia… - Cell reports, 2018 - cell.com
Assays that can characterize MSC immune potency need to be identified for use in
advanced clinical trials. MSCs possess a number of putative regenerative and …

Cryopreserved mesenchymal stromal cells are susceptible to T-cell mediated apoptosis which is partly rescued by IFNγ licensing

R Chinnadurai, IB Copland, MA Garcia… - Stem Cells, 2016 - academic.oup.com
We have previously demonstrated that cryopreservation and thawing lead to altered
Mesenchymal stromal cells (MSC) functionalities. Here, we further analyzed MSC's fitness …

Mesenchymal stem cells for perianal Crohn's disease

M Carvello, A Lightner, T Yamamoto, PG Kotze… - Cells, 2019 - mdpi.com
Perianal fistulizing Crohn's disease (PFCD) is associated with significant morbidity and
might negatively impact the quality of life of CD patients. In the last two decades, the …

The necrobiology of mesenchymal stromal cells affects therapeutic efficacy

DJ Weiss, K English, A Krasnodembskaya… - Frontiers in …, 2019 - frontiersin.org
Rapid progress is occurring in understanding the mechanisms underlying mesenchymal
stromal cell (MSC)-based cell therapies (MSCT). However, the results of clinical trials, while …

Novel insights into MSC-EVs therapy for immune diseases

P Lai, J Weng, L Guo, X Chen, X Du - Biomarker Research, 2019 - Springer
Mesenchymal stromal cells (MSC) are a heterogeneous cell population with self-renewal
and the ability to differentiate into different lineages. The novel regulatory role of MSC in …

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease–a phase 1 trial with three doses

T Dhere, I Copland, M Garcia… - Alimentary …, 2016 - Wiley Online Library
Background Mesenchymal stromal cells ability to reset immune functionalities may be useful
in Crohn's disease. Aim To perform a first‐in‐human phase 1 safety clinical trial of …